C 93 (Rivastigmine Tartrate 4.5 mg)
Pill with imprint C 93 is Red, Capsule-shape and has been identified as Rivastigmine Tartrate 4.5 mg. It is supplied by Cadila Pharmaceuticals Limited.
Rivastigmine is used in the treatment of alzheimer's disease; parkinson's disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 4.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C 93
Rivastigmine Tartrate
- Imprint
- C 93
- Strength
- 4.5 mg
- Color
- Red
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cadila Pharmaceuticals Limited
- National Drug Code (NDC)
- 71209-0014
- Inactive Ingredients
-
hypromelloses,
microcrystalline cellulose,
silicon dioxide,
magnesium stearate,
gelatin,
titanium dioxide,
ferric oxide yellow,
ferric oxide red
Note: Inactive ingredients may vary.
Related Images for "C 93"
More about rivastigmine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- 30 Reviews
- Drug class: cholinesterase inhibitors
Consumer resources
- Patient Information
- Rivastigmine transdermal
- Rivastigmine (Advanced Reading)
- Rivastigmine Transdermal (Advanced Reading)
- Rivastigmine Capsules
- ... +2 more
- Other brands
- Exelon
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.